Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.

CompletedOBSERVATIONAL
Enrollment

1,007

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Chemotherapy-induced Febrile Neutropenia
Trial Locations (90)

1030

Research Site, Vienna

1090

Research Site, Vienna

2485

Research Site, Tweed Heads

3550

Research Site, Bendigo

3630

Research Site, Shepparton

3690

Research Site, Wodonga

3730

Research Site, Eggenburg

4840

Research Site, Vöcklabruck

8036

Research Site, Graz

8700

Research Site, Leoben

10125

Research Site, Torino

10317

Research Site, Berlin

11522

Research Site, Athens

11525

Research Site, Athens

11527

Research Site, Athens

13009

Research Site, Marseille

14564

Research Site, Nea Kifissia, Athens

18107

Research Site, Rostock

18435

Research Site, Stralsund

18547

Research Site, Athens

20900

Research Site, Monza (MB)

21005

Research Site, Huelva

21100

Research Site, Varese

25030

Research Site, Besançon

27239

Research Site, Twistringen

29010

Research Site, Málaga

29609

Research Site, Brest

30103

Research Site, Alès Cédex

30900

Research Site, Nîmes

31008

Research Site, Pamplona

33170

Research Site, Pordenone

36043

Research Site, Fulda

38043

Research Site, Grenoble

38320

Research Site, San Cristóbal de La Laguna

41110

Research Site, Larissa

46015

Research Site, Valencia

47005

Research Site, Valladolid

50009

Research Site, Zaragoza

50134

Research Site, Florence

53111

Research Site, Bonn

54636

Research Site, Thessaloniki

54645

Research Site, Thessaloniki

55131

Research Site, Mainz

57010

Research Site, Thessaloniki

62000

Research Site, Arras

69400

Research Site, Villefranche-sur-Saône

69495

Research Site, Pierre-Bénite

71100

Research Site, Foggia

73300

Research Site, Chania

83056

Research Site, Toulon

89124

Research Site, Reggio Calabria

92202

Research Site, Neuilly-sur-Seine

94010

Research Site, Créteil

95122

Research Site, Catania

110084

Research Site, Piteşti

300167

Research Site, Timișoara

300239

Research Site, Timișoara

400006

Research Site, Cluj-Napoca

400352

Research Site, Cluj-Napoca

410469

Research Site, Oradea

500052

Research Site, Brasov

500152

Research Site, Brasov

601048

Research Site, Onești

620165

Research Site, Focşani

700483

Research Site, Iași

720237

Research Site, Suceava

810325

Research Site, Brăila

E1C 6Z8

Research Site, Moncton

P6B 0A8

Research Site, Sault Ste. Marie

H2W 1T8

Research Site, Montreal

03100

Research Site, Montluçon

02321

Research Site, Saint-Quentin

01844

Research Site, Neustadt/Sachsen

Unknown

Research Site, Cork

Research Site, Galway

00128

Research Site, Roma

15-027

Research Site, Bialystok

85-796

Research Site, Bydgoszcz

82-300

Research Site, Elblag

81-519

Research Site, Gdynia

90-722

Research Site, Lodz

93-509

Research Site, Lodz

71-730

Research Site, Szczecin

02-781

Research Site, Warsaw

50-981

Research Site, Wroclaw

030171

Research Site, Bucharest

07198

Research Site, Palma de Mallorca

05004

Research Site, Ávila

08003

Research Site, Barcelona

08035

Research Site, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY